/Sponsor / Executive Profile

Chris Ehrlich

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Chris Ehrlich has been our Chief Executive Officer and Director since October 2020. Since May 2013, Mr. Ehrlich has served as Senior Managing Director and Head of Locust Walk Partners’ Global Biopharma team.

Total Capital Deployed

$527,900,000

Active / Searching Capital:
-

Transaction Volume

3 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Immunotherapy1 Deals
  • biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
LPAA
Launch One Acquisition Corp.
closed
200.0M
$10.00
1/2Jun 2024Done-GeneralCantor Fitzgerald & Co.
CERO
Phoenix Biotech Acquisition Corp.
closed
158.1M
$2.00
1/2Sep 2021Done-ImmunotherapyCantor Fitzgerald & Co.
EFTR
Locust Walk Acquisition Corp.
closed
169.8M
$10.00
1/3Dec 2020Done-biopharmaceuticalCantor Fitzgerald & Co.